Literature DB >> 26466598

Ocular adnexal and orbital amyloidosis: a case series and literature review.

Eduardo R Mora-Horna1, Rubí Rojas-Padilla2, Vianhi G López3, Martín J Guzmán3, Ariel Ceriotto3, Guillermo Salcedo3.   

Abstract

The purpose of the study was to describe the main clinical and epidemiologic characteristics, treatment options, and outcome in a large series of patients with periocular and orbital amyloidosis. This is a retrospective, descriptive, observational study of a case series of 14 patients with periocular and orbital amyloidosis and is a review of previously published cases with this diagnosis between September 2004 and January 2015. In this study, we analyzed our 14 patients in conjunction with 69 well-documented cases of orbital and/or periocular amyloidosis previously reported, with a total of 83. Of these, 54 were female (65.1 %), 28 male (33.7 %), and one with unspecified gender. The mean age at diagnosis was 54.9 years (range, 18-87). The localization of the amyloidosis was classified as superficial, deep and combined, with involvement of 53 (63.9 %), 26 (31.3 %), and four cases (4.8 %) in each group, respectively. The main findings in superficial amyloidosis were mass or tissue infiltration (84.9 %) and ptosis (30.2 %) and, in the cases with deep involvement, mass (65.4 %), proptosis (57.7 %), limited ocular movements (34.6 %), ocular displacement (30.8 %), and ptosis (26.9 %). The cases with combined involvement presented with signs and symptoms of the two groups. Regarding the outcome, 43 patients were reported stable after the diagnosis and 21 had recurrence or required new surgical procedures. Periocular and orbital amyloidosis is a rare disease that can present with a variety of symptoms and signs depending on the localization and extension of involvement. Its prompt recognition is important in order to investigate systemic disease, which will affect the prognosis of each case.

Entities:  

Keywords:  Adnexal; Amyloidosis; Conjunctival; Lacrimal; Orbital

Mesh:

Year:  2015        PMID: 26466598     DOI: 10.1007/s10792-015-0138-7

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  64 in total

1.  Orbital amyloidosis-induced compressive optic neuropathy accompanied by characteristic eyelid pigmentation.

Authors:  Akio Oishi; Kazuaki Miyamoto; Nagahisa Yoshimura
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2006 Nov-Dec       Impact factor: 1.746

2.  Vicarious menstruation in primary localized conjunctival amyloidosis.

Authors:  Vinod Gauba; Matthew Cooper; Christopher Liu
Journal:  Arch Ophthalmol       Date:  2006-09

3.  Secondary amyloidosis manifesting as bilateral blepharoedema.

Authors:  Hideki Maejima; Kouju Kamata; Kensei Katsuoka; Toshihiro Matsui
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437

Review 4.  Conjunctival amyloidosis: report of six cases and review of the literature.

Authors:  Hakan Demirci; Carol L Shields; Ralph C Eagle; Jerry A Shields
Journal:  Surv Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 6.048

5.  Nodular amyloidosis of all four eyelids: first presenting symptom of Waldenström macroglobulinaemia.

Authors:  Stine Jacoby; Peter B Toft; Jan U Prause; Preben Philip; Steffen Heegaard
Journal:  Acta Ophthalmol       Date:  2013-04-22       Impact factor: 3.761

6.  Primary localized conjunctival amyloidosis: A case report with a ten-year follow-up period.

Authors:  Juan Carlos Mesa-Gutiérrez; Tomás Martí Huguet; Noemí Barnils Garcia; Jorge Arruga Ginebreda
Journal:  Clin Ophthalmol       Date:  2008-09

7.  Liquid nitrogen cryotherapy for conjunctival amyloidosis.

Authors:  Frederick W Fraunfelder
Journal:  Arch Ophthalmol       Date:  2009-05

Review 8.  Amyloidosis.

Authors:  Mark B Pepys
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

9.  Primary conjunctival amyloidosis.

Authors:  Chandana Chakraborti; Krittika P Chaudhury; Ranu Roy Biswas
Journal:  Oman J Ophthalmol       Date:  2014-01

10.  Unilateral conjunctival AL kappa amyloidosis with trace evidence of systemic amyloidosis.

Authors:  Al-Ola Abdallah; Christopher Westfall; Harry Brown; Jameel Muzaffar; Shebli Atrash; Bijay Nair
Journal:  Am J Case Rep       Date:  2012-06-06
View more
  8 in total

1.  Long-Term Follow-Up of 4 Patients with Conjunctival Amyloidosis.

Authors:  Alisa J Prager; Larissa A Habib; Talita Gambogi; Klaus J Busam; Brian P Marr
Journal:  Ocul Oncol Pathol       Date:  2018-02-13

2.  Long-term follow-up of a case of amyloidosis-associated chorioretinopathy.

Authors:  Koichi Nagura; Tatsuya Inoue; Jared Ching; Akinori Sato; Shohei Kitahata; Maiko Maruyama-Inoue; Masaru Takeuchi; Kazuaki Kadonosono
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-02

3.  Yellow subconjunctival deposits.

Authors:  Ofira Zloto; Mordechai Rosner; Vicktoria Vishnevskia-Dai
Journal:  BMJ Case Rep       Date:  2019-08-01

Review 4.  Rare Diseases of the Orbit.

Authors:  Ulrich Kisser; Jens Heichel; Alexander Glien
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

5.  Clinicopathologic and Proteomic Analysis of Amyloidomas Involving the Ocular Surface and Adnexa.

Authors:  Pouya Jamshidi; Jonathan Levi; Maria Jose Suarez; Roxana Rivera; Nicholas Mahoney; Charles G Eberhart; Avi Rosenberg; Fausto J Rodriguez
Journal:  Am J Clin Pathol       Date:  2022-04-01       Impact factor: 2.493

6.  Primary isolated amyloidosis in the extraocular muscle as a rare cause of ophthalmoplegia: A case report and literature review.

Authors:  Noriko Nishikawa; Yuriya Kawaguchi; Ami Konno; Yuya Kitani; Hidehiro Takei; Yasuo Yanagi
Journal:  Am J Ophthalmol Case Rep       Date:  2021-02-26

7.  A Rare Case of Amyloidosis of the Eyelid and Conjunctiva.

Authors:  Zaria Ali; Bertie Fernando
Journal:  Case Rep Ophthalmol Med       Date:  2016-09-26

8.  Intraocular amyloidosis with multifocal iris and anterior chamber translucent spherules.

Authors:  Sima Das; Sweety Tiple; Julie Pegu; Suneeta Dubey; Umang Mathur; Kaustabh Mulay; Carol L Shields
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.